Tohko Arai

2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 1: discovery of CB2 receptor selective compounds.

K. Kawamoto, H. Nakazato, H. Kai, 2007, Bioorganic & medicinal chemistry letters.

Pharmacological Profile of Naldemedine, a Peripherally Acting μ-Opioid Receptor Antagonist: Comparison with Naloxone and Naloxegol

K. Takase, A. Nakamura, T. Kanemasa, 2020, The Journal of Pharmacology and Experimental Therapeutics.

Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with beta-lactam antibiotics.

K. Abe, M. Kimura, Nobuyoshi Hasebe, 2006, Toxicology.

Pharmacologic effects of naldemedine, a peripherally acting μ‐opioid receptor antagonist, in in vitro and in vivo models of opioid‐induced constipation

A. Nakamura, H. Ono, T. Kanemasa, 2019, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.